Markets:

Overview

News

Currencies

International

Treasuries

Zimmer Holdings (NY:ZBH)

93.21 -1.75 (-1.84%)

Streaming Delayed Price Updated: 11:52 AM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2022 ↗

January 10, 2022

Upgrades According to Mizuho, the prior rating for Xcel Energy Inc (NASDAQ:

Via Benzinga

Analyst Ratings For Zimmer Biomet Holdings ↗

January 04, 2022

Over the past 3 months, 7 analysts have published their opinion on Zimmer Biomet Holdings (NYSE:

Via Benzinga

Expert Ratings For Zimmer Biomet Holdings ↗

December 21, 2021

Over the past 3 months, 7 analysts have published their opinion on Zimmer Biomet Holdings (NYSE:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗

January 07, 2022

Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:

Via Benzinga

Expert Ratings For Zimmer Biomet Holdings ↗

December 07, 2021

Over the past 3 months, 4 analysts have published their opinion on Zimmer Biomet Holdings (NYSE:

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

January 07, 2022

UBS cut the price target for Kohl's Corporation (NYSE:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2022 ↗

January 04, 2022

Upgrades According to Vertical Research, the prior rating for Livent Corp (NYSE:

Via Benzinga

Analyzing Zimmer Biomet Holdings's Unusual Options Activity ↗

August 03, 2021

On Tuesday, shares of Zimmer Biomet Holdings (NYSE:ZBH) saw ...

Via Benzinga

Recap: Zimmer Biomet Q2 Earnings ↗

August 03, 2021

Shares of Zimmer Biomet Holdings (NYSE:ZBH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 3700.00% over the past year...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 ↗

December 10, 2021

Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:

Via Benzinga

2 Medical Device Stocks Wall Street Predicts Will Rally 35% Or More ↗

December 09, 2021

Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021 ↗

December 09, 2021

Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:

Via Benzinga

7 F-Rated Dividend Stocks You Shouldn’t Get Suckered Into ↗

December 08, 2021

As dividend stocks, these companies aren’t worth a second glance, even though some boast tempting dividend yields.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021 ↗

December 07, 2021

Upgrades For CarMax Inc (NYSE:

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

November 05, 2021

Wedbush raised Uber Technologies, Inc. (NYSE:UBER)...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021 ↗

November 23, 2021

Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE:

Via Benzinga

Zimmer Biomet Holdings Inc (ZBH) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

ZBH earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Zimmer Biomet Shares Hit After Lowering Annual Guidance ↗

November 04, 2021

Zimmer Biomet Holdings Inc's (NYSE: ZBH) Q3 sales decreased marginally by 0.3% Y/Y to $1.92 billion (down 0.8% on a constant currency basis), missing the...

Via Benzinga

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

Price Over Earnings Overview: Zimmer Biomet Holdings ↗

November 02, 2021

Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE:ZBH) is trading at $145.73, after a 0.1% decrease. Over the past month, the stock fell by 0.64%,...

Via Benzinga

Software Error Prompts Zimmer Biomet To Recall Rosa One Robotic Neurosurgery Platform ↗

November 01, 2021

Zimmer Biomet Holdings Inc (NYSE: ZBH) is facing a Class I recall of its Rosa One Brain platform. Devices ranging from biopsy needles to endoscopes to deep brain...

Via Benzinga

Topics Product Recall

Zimmer Biomet Scores FDA De Novo Nod For Smart Knee Implant ↗

August 30, 2021

Zimmer Biomet Holdings Inc (NYSE: ZBH) and Canary Medical have announced that the FDA granted de novo classification for Persona IQ. The de novo grant...

Via Benzinga

FDA Approves Zimmer Biomet's Rosa Hip Personalized Robotic System ↗

August 18, 2021

Zimmer Biomet Holdings Inc (NYSE: ZBH) has received FDA 510(k) clearance for its Rosa Hip system for robotically-assisted surgery. The system is designed for...

Via Benzinga

Zimmer Biomet Holdings Inc (ZBH) Q2 2021 Earnings Call Transcript ↗

August 03, 2021

ZBH earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Zimmer Biomet Stock Falls After Lowering Bottom End Of FY21 Outlook; Q2 Earnings Beat ↗

August 03, 2021

Zimmer Biomet Holdings Inc (NYSE: ZBH) posted Q2 adjusted EPS of $1.90, ahead of the consensus of $1.87 and higher than $0.05 posted a year ago. It reported a profit of...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Earnings Scheduled For August 3, 2021 ↗

August 03, 2021

Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...

Via Benzinga

A Look Into Zimmer Biomet's Price Over Earnings ↗

July 30, 2021

Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE:ZBH) is trading at $162.42, after a 0.20% drop. Over the past month, the stock decreased by 0.68...

Via Benzinga

This Part of the Reopening Trade Is Just Getting Started ↗

June 05, 2021

As hospitals address the major backlog of pandemic-postponed elective surgeries, medical device makers -- and their stock prices -- could benefit.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗

May 25, 2021

Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.